Health

Postpartum depression may affect men too: researchers say

Postpartum depression may affect men too: researchers say

Women are not the only group that can suffer postpartum depression as a new study has revealed that even fathers-to-be can also face a significant risk of developing this condition.

While the stigma around postpartum depression is fading away and many new mothers are openly discussing their condition and are reaching out for help; few know that this disorder also affects new fathers.

Small percentage of patients found responsible for spreading lethal Ebola epidemic

Small percentage of patients found responsible for spreading lethal Ebola epidemic

A small percentage of so-called “superspreaders” was likely responsible for spreading the lethal Ebola epidemic that left thousands of people dead in West Africa, according to a new study.

A team of experts from New Jersey’s Princeton University and the Oregon State University estimated that merely 3 per cent of people infected with the Ebola virus were the source for more than 61 per cent of all cases of the deadly disease in Western African countries.

Study links heavy snowfall to higher heart attack risk for men

Study links heavy snowfall to higher heart attack risk for men

A fresh Canadian study has suggested that men may be at a notably higher risk of suffering a fatal heart attack following a heavy snowstorm.

Researchers from the University of Montreal found in the study that compared with periods without snow, men were 16 per cent more probable to suffer a heart attack and 34 per cent more probable to die from a heart attack after a storm dropped at least 8 inches of snow.

High price may keep deflazacort drug out of several patients’ reach

High price may keep deflazacort drug out of several patients’ reach

A drug recently approved by the Food & Drug Administration (FDA) to treat a rare form of muscular dystrophy may be out of reach of many patients due to its hefty price.
Marathon Pharmaceuticals will sell the FDA-approved deflazacort drug under the brand name Emflaza for nearly $89,000 for a year’s worth of treatment. The figure represents 70 times higher price for the drug than what it costs outside the United States.

Debate over Planned Parenthood funding continues

Debate over Planned Parenthood funding continues

U. S. President Donald Trump and other Republicans have threatened to eliminate federal funding for Planned Parenthood because clinics operating under the organization provide abortion services as well.

This Saturday, the debate over the issue will peak with protest rallies across the nation, including at clinics in San Francisco, Redwood City and Napa, demanding "defunding" of Planned Parenthood.

MDA welcomes FDA approval for muscular dystrophy drug

MDA welcomes FDA approval for muscular dystrophy drug

The Muscular Dystrophy Association (MDA) has welcomed the U.S. Food & Drug Administration’s decision to approve Marathon Pharmaceuticals’ deflazacort drug to treat the most common childhood form of muscular dystrophy.

The deflazacort drug, labeled for use by individuals 5 years or older with Duchenne muscular dystrophy (DMD), can be used regardless of genetic mutation. It is third drug in 6 months approved by the FDA for diseases included in MDA’s program.

Pages

Contact

Whether you want to ask us a question, would like to solve a problem, or just give us a suggestion, you’ll find many ways to contact us right here.

Email: [email protected]

Phone: (916) 225-9835

Fax: (916) 225-9845

Newsletters

Subscribe and get the latest updates, news and more...